Sesquiterpene hybrid hydroquinone compounds and preparation method and application thereof

A technology of compounds and fermented products, which is applied in the field of preparation of anti-H1N1 influenza drugs, and can solve problems such as drugs that have not yet been seen

Inactive Publication Date: 2011-04-06
OCEAN UNIV OF CHINA
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies have found that the shown sesquiterpene catechol compounds have strong anti-influenza A (H1N1) virus activity. There is no report on the chemical structure of the compound and anti-influenza A (H1N1) virus. drugs associated with it

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sesquiterpene hybrid hydroquinone compounds and preparation method and application thereof
  • Sesquiterpene hybrid hydroquinone compounds and preparation method and application thereof
  • Sesquiterpene hybrid hydroquinone compounds and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Example 1 Fermentative production and separation and purification of compounds

[0013] 1 Fermentation production

[0014] Fermentation culture of production bacteria: according to the conventional method of cultivating microorganisms, get an appropriate amount of Alternaria sp-32 (Alternaria sp.) (preservation number is: CCTCC M 2010044), inoculate it on the PDA solid slant medium, and incubate at 28 degrees centigrade. cultured for 4 days.

[0015] Take an appropriate amount of Alternaria sp. SP-32 (Alternaria sp.) that has been cultured on a slant for 4 days, and inoculate it into 200 mL of culture fluid [medium composition (g / L): maltose 20.0, mannitol 20.0, monosodium glutamate 10.0, KH 2 PO 4 0.5, MgSO 4 0.3, yeast extract 3.0, pH natural] in a 500mL Erlenmeyer flask, cultured on a shaking table at 28°C and 160 rpm for 8 days to obtain mycelium and fermentation broth.

[0016] 2 Obtaining the extract

[0017] Separate the mycelium and fermentation broth wit...

Embodiment 2

[0026] The test of embodiment 2 in vitro anti-H1N1 virus activity

[0027] 1. Experimental samples and experimental methods

[0028] Preparation of the test sample solution The test sample is the pure compound I isolated and refined in the above-mentioned Example 1. Precisely weigh an appropriate amount of sample, and prepare a solution with the required concentration with DMSO for activity measurement.

[0029] The cultivation of virus strains and infected cell lines Infection dog kidney epithelial cells (MDCK) with influenza A virus strain [A / PR / 8 / 34 (H1N1)], and adding the sample to be tested into the cell maintenance solution (excluding Serum) was subcultured in an incubator with 5% carbon dioxide at 37 degrees Celsius, and then the CPE (cytopathic change) of the infected cells was observed with an inverted microscope.

[0030] Tetrazolium salt (MTT) method Take dog kidney epithelial cells (MDCK) cells in the logarithmic growth phase, and adjust the cell density to 2×10 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation method and application of two sesquiterpene hybrid hydroquinone compounds. The sesquiterpene hybrid hydroquinone compounds with novel structures are produced by adopting alternaria sp. SP-32 in a South China Sea sponge sample. Proved by experiments, the compounds have flu virus A H1N1 resistant effect, and have potential for developing flu virus A resistant medicament preparations.

Description

Technical field: [0001] The present invention relates to the method for producing sesquiterpene catechol compounds with Alternaria sp. SP-32 (Alternaria sp.) (preservation number: CCTCC M2010044); Use in flu medicines. Background technique: [0002] Sesquiterpene mixed phenols are active mixed terpenoids that are mostly produced in invertebrates such as sponges and sea squirts, but Alternaria as its source has not been reported. The inventors have studied and learned that Alternaria sp. SP-32 (Alternaria sp.) (preservation number: CCTCC M 2010044, preservation date: February 5, 2010, preservation unit: China Typical Culture Collection Center, address: Wuhan City, Wuhan University) liquid fermentation product after ultrasonic crushing crude extract has a very good anti-H1N1 influenza virus proliferation, then its active ingredients were studied. Studies have found that the shown sesquiterpene catechol compounds have strong anti-influenza A (H1N1) virus activity. There is no...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C43/23C12P7/22A61K31/085A61P31/16C12R1/645
Inventor 李德海顾谦群张国建朱天骄
Owner OCEAN UNIV OF CHINA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap